Phase None Completed NCT01926249

A Cohort of Outpatients From French Research Memory Centers in Order to Improve Knowledge on Alzheimer's Disease and Related Disorders

University Hospital, Bordeaux · Observational

10 views
Rate this page
Completed October 2021. Read the results summary below →

Study context: no flags matched. Amendment history is not available for this trial's data source.

Overview

A Multicenter national prospective cohort study including at least 2300 individuals consecutively recruited from French Research Memory Centers and followed-up over 5 years.

Full record on ClinicalTrials.gov (NCT ID NCT01926249).

Results summary

None

Outcome data

EndpointTypeResultSignificance
Progression to clinical dementia stage according to standardized classifications (DSM-IV for dementia and NINCDS-ADRDA for Alzheimer's disease) Primary None None
Mortality Secondary None None
Loss of autonomy based on functional activity assessment Secondary None None
Institutionalisation Secondary None None
Speed of cognitive decline based on change in cognitive performances Secondary None None
Cardiovascular event (Stroke and Coronary events) Secondary None None
Quality of life Secondary None None
Prodromal AD (Pre-symptomatic dementia) Secondary None None
Longitudinal evolution of biomarkers measured from blood, Cerebro-Spinal Fluid (CSF), structural neuroimaging (MRI) and molecular neuroimaging (18F-FDG PET) Secondary None None

Full results record on ClinicalTrials.gov.

Study design

Phase
Phase None
Study type
Observational
Enrollment (final)
2,325 participants
Started
December 2011
Actually completed
October 2021

Recruitment criteria

Age range: ≥ 18 · Sex: All · Healthy volunteers: Requires diagnosis

Locations

29 sites participated during the trial period. Representative sites shown below; full historical record on ClinicalTrials.gov.

CHU d'Amiens — Amiens (France)
CHU d'Angers — Angers (France)
CHU de Besançon — Besançon (France)
AP-HP - Avicenne — Bobigny (France)
CHU de Bordeaux - Pellegrin — Bordeaux (France)
CHU de Bordeaux - Hôpital Xavier-Arnozan — Bordeaux (France)
CHU de Brest — Brest (France)
CHU de Clermont-Ferrand — Clermont-Ferrand (France)
Hôpitaux civils de Colmar — Colmar (France)
CHU de Dijon — Dijon (France)
CHU de Grenoble — Grenoble (France)
CHU de Lille — Lille (France)
Hospices civils de Lyon — Lyon (France)
AP-HM — Marseille (France)
CHU de Montpellier — Montpellier (France)
CHU de Nancy — Nancy (France)
CHU de Nantes — Nantes (France)
CHU de Nice — Nice (France)
AP-HP - Hôpital BROCA — Paris (France)
AP-HP - Hôpital LARIBOISIERE — Paris (France)
Ap-Hp La Pitié-Salpêtrière — Paris (France)
CHU de Poitiers — Poitiers (France)
CHU de Rouen — Rouen (France)
CHU de Saint-Etienne - Hôpital de la charité — Saint-Etienne (France)
CHU de Saint-Etienne - Hôpital Nord — Saint-Etienne (France)
CHU de Strasbourg — Strasbourg (France)
CHU de Toulouse - Hôpital Purpan — Toulouse (France)
CHU de Toulouse — Toulouse (France)
CHU de Tours — Tours (France)

Sources

REG
ClinicalTrials.gov — NCT01926249
Trial registry · primary record
How would you rate this page?
Your feedback helps us improve the quality of our content.
What did you like about this page?
What did you not like about this page?
Is there anything else you'd like to see covered?
Report an error
All reports are reviewed before any changes are made.
What type of error are you reporting?
Which section does this relate to?
Please describe the error
Be as specific as possible — include the correct information if you know it.
Highlight mode — select the text containing the error
Click and drag over the relevant text, then click Confirm.
Thank you
Your response helps us improve the quality of this page.